ClinSpec Diagnostics Spin-out

ClinSpec Diagnostics are delighted to announce the completion of seed investment to spin-out of the University of Strathclyde, following a mixture of almost £1.6 million in equity and grant funding.

We are delighted to be working alongside our new investors and collaborators, and look forward to sharing our future plans with you all soon.

https://www.strath.ac.uk/whystrathclyde/news/life-savingbraincancerbloodtestbeingdeveloped/



Recent Posts

See All

Cancer diagnostics company, Dxcover Limited, has published its latest data from clinical studies on earlier detection of aggressive cancers. The study[i] involving over 980 patients suffering from non